ArticleJournal of cheminformatics2025
A resource description framework (RDF) model of named entity co-occurrences in biomedical literature and its integration with PubChemRDF.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Screening of key host targets and mechanistic assessment of berberine modulation of host responses to respiratory syncytial virus.The Journal of international medical research · 2026Article
- Database resources of the National Center for Biotechnology Information in 2026.Nucleic acids research · 2026Article
- Study on the inhibitory effect of geniposide on coxsackievirus and its mechanism.Frontiers in pharmacology · 2026Article
- A resource description framework (RDF) model of named entity co-occurrences in biomedical literature and its integration with PubChemRDF.Journal of cheminformatics · 2025Article
- A systematic exploration of unexploited genes for oxidative stress in Parkinson's disease.NPJ Parkinson's disease · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Named entities, such as chemicals/drugs, genes/proteins, and diseases, and their associations are not only important components of biomedical literature, but also the foundation of creating biomedical knowledgebases and knowledge graphs. This work addresses the challenges of expressing co-occurrence associations between named entities extracted from a biomedical literature corpus in a machine-readable format. We developed a Resource Description Framework (RDF) data model and integrated it into the PubChemRDF resource, which is freely accessible and publicly available. The developed co-occurrence data model was populated into a triplestore with named entities and their associations derived from text mining of millions of biomedical references found in PubMed. The utility of the data model was demonstrated through multiple use cases. Together with meta-data modeling of the references including the information about the author, journal, grant, and funding agency, this data model allows researchers to address pertinent biomedical questions through SPARQL queries and helps to exploit biomedical knowledge in various user perspectives and use cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.